Concord Drugs Stock Screener | Share Price & Fundamental Analysis
CONCORD
Pharmaceuticals
Screen Concord Drugs share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹84.55
▼
-0.45 (-0.53%)
Market Cap
₹86.94 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.41
EPS (TTM)
₹0.34
Dividend Yield
-
Debt to Equity
0.54
52W High
₹88.15
52W Low
₹27.46
Operating Margin
10.00%
Profit Margin
-
Revenue (TTM)
₹10.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹65.00
Total Equity
₹34.00
Concord Drugs Share Price History - Stock Screener Chart
Screen CONCORD historical share price movements with interactive charts. Analyze price trends and patterns.
Concord Drugs Company Profile - Fundamental Screener
Screen Concord Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CONCORD shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE858L01010
Concord Drugs Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen CONCORD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 65 | 59 | 58 | 56 |
| Current Assets | 41 | 38 | 44 | 42 |
| Fixed Assets | 12 | 12 | 13 | 14 |
| Liabilities | ||||
| Total Liabilities | 65 | 59 | 58 | 56 |
| Current Liabilities | 5 | 4 | 5 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 34 | 34 | 32 | 28 |
| Share Capital | 10 | 10 | 9 | 9 |
| Reserves & Surplus | 24 | 24 | 22 | 20 |
Screen CONCORD income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 14 | 10 | 16 | 12 | 12 | 11 | 12 | 9 | 8 | 13 | 16 | 13 | 14 | 14 |
| Expenses | 9 | 13 | 9 | 15 | 11 | 12 | 9 | 11 | 8 | 6 | 12 | 15 | 12 | 13 | 12 |
| EBITDA | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 10.00% | 7.00% | 11.00% | 2.00% | 7.00% | 7.00% | 13.00% | 8.00% | 16.00% | 21.00% | 5.00% | 4.00% | 8.00% | 9.00% | 11.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | -1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.04 | 0.12 | 0.19 | -0.34 | 0.03 | 0.04 | 0.23 | 0.17 | 0.53 | 0.60 | -0.24 | 0.03 | 0.21 | 0.21 | 0.52 |
Concord Drugs Cash Flow Screener - Liquidity Fundamentals
Screen CONCORD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 4 | 1 | 2 | 1 |
| Investing Activities | -2 | -1 | -2 | -2 |
| Financing Activities | -1 | 0 | 1 | 2 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
Screen CONCORD shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 54.39% | 54.39% | 54.39% | 54.39% | 54.39% | 55.41% | 55.41% | 55.41% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 44.95% | 42.57% | 43.33% | 45.11% | 45.11% | 44.30% | 44.28% | 44.27% |
| Other Holding | 0.66% | 3.04% | 2.28% | 0.50% | 0.50% | 0.29% | 0.31% | 0.32% |
| Shareholder Count | 4,718 | 5,189 | 5,252 | 5,073 | 5,073 | 4,755 | 4,734 | 4,032 |
Concord Drugs Dividend Screener - Share Yield Analysis
Screen CONCORD dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Concord Drugs Index Membership - Market Screener Classification
Screen CONCORD by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Concord Drugs Market Events Screener - Corporate Actions
Screen CONCORD market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.66% | ||
| Annual General Meeting | NA | -1.64% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 31.55% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -2.24% |
| 2025-07-31 | 2025-07-31 | Extraordinary General Meeting | NA | 0.94% |
| 2025-07-30 | 2025-07-30 | Extraordinary General Meeting | NA | 8.84% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | -0.03% |
| 2025-01-11 | 2025-01-11 | Quarterly Result Announcement | NA | -1.79% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -3.25% |
Concord Drugs Competitors Screener - Peer Comparison
Screen CONCORD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,587 | 40.16 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 173,192 | 69.16 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,266 | 60.40 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 121,672 | 22.30 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 107,031 | 18.66 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,183 | 22.21 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 93,736 | 18.57 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 92,516 | 51.90 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 71,026 | 20.66 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,789 | 27.75 | 13,458 | 3.70% | 2,216 | 47.48 |
Concord Drugs Company Announcements - News Screener
Screen CONCORD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-25 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-25 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-25 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 | View |
| 2025-11-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-20 | Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Equity Shares And Convertible Warrants | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-13 | Financial Results For Quarter Ended 30 Sep 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-04 | Board Meeting Intimation for Quarterly Results | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-09 | Reg. 34 (1) Annual Report. | View |
| 2025-09-08 | Letter To Shareholders | View |
| 2025-09-08 | Annual Report | View |
| 2025-09-08 | Notice For AGM | View |
| 2025-09-08 | Record Date For AGM | View |